Pulmonary embolism in patients with CKD and ESRD

Clinical Journal of the American Society of Nephrology

Volumn 7, Issue 10, 2012, Pages 1584-1590

  Kumar, Gagan ^a   Sakhuja, Ankit ^b   Taneja, Amit ^a   Majumdar, Tilottama ^a   Patel, Jayshil ^a   Whittle, Jeff ^a,c   Nanchal, Rahul ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HUMAN; INCIDENCE; KIDNEY DISEASE; KIDNEY FUNCTION; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; RISK FACTOR; SMOKING;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; LENGTH OF STAY; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PULMONARY EMBOLISM; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; THROMBOLYTIC THERAPY; TIME FACTORS; UNITED STATES; VENA CAVA FILTERS; YOUNG ADULT;

EID: 84867255666     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00250112     Document Type: Article

References (44)

1. US Renal Data System: Incidence and prevalence. In: Atlas of End-Stage Renal Disease. Available at: http://www.usrds.org/2009/pdf/V2_02_INC_PREV_09.pdf. Accessed November 10, 2011
2. US Renal Data System: Chronic kidney disease in the adult NHANES population. In: Atlas of Chronic Kidney Disease. Available at: http://archive.usrds.org/2009/pdf/V1_01_09.PDF. Accessed November 10, 2011
3. US Renal Data System: RenDER. Available at: http://www.usrds.org/render/xrender.phtml. Accessed March 3, 2012
4. US Centers for Disease Control and Prevention: National Chronic Kidney Disease Fact Sheet, 2010. Available at: http://www.cdc.gov/diabetes/pubs/pdf/kidney_Factsheet.pdf. Accessed July 10, 2012
5. US Renal Data System: Chronic disease in the general population. In: 2011 USRDS Annual Data Report. Available at: http://www.usrds.org/2011/pdf/v1_ch01_11.pdf. Accessed June 30, 2012
6. US Renal Data System: 2011 USRD Annual Data Report: Atlas of End-Stage Renal Disease in theUnited States, Vol. 2. Available at: http://www.usrds.org/2011/slides/indiv/v2index.html. Accessed June 30, 2012
7. Ploth DW, Shepp PH, Counts C, Hutchison F: Prospective analysis of global costs for maintenance of patients with ESRD. Am J Kidney Dis 42: 12-21, 2003
8. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd: Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Arch Intern Med 158: 585-593, 1998
9. Tapson VF: Acute pulmonary embolism. N Engl J Med 358: 1037-1052, 2008
10. Horlander KT, Mannino DM, Leeper KV: Pulmonary embolism mortality in the United States, 1979-1998:An analysis usingmultiplecause mortality data. Arch Intern Med 163: 1711-1717, 2003
11. Wattanakit K, Cushman M, Stehman-Breen C, Heckbert SR, Folsom AR: Chronic kidney disease increases risk for venous thromboembolism. J Am Soc Nephrol 19: 135-140, 2008
12. Wattanakit K, Cushman M: Chronic kidney disease and venous thromboembolism: Epidemiology and mechanisms. Curr Opin Pulm Med 15: 408-412, 2009
13. Folsom AR, Lutsey PL, Astor BC, Wattanakit K, Heckbert SR, Cushman M; Atherosclerosis Risk in Communities Study: Chronic kidney disease and venous thromboembolism: A prospective study. Nephrol Dial Transplant 25: 3296-3301, 2010
14. Mahmoodi BK, Gansevoort RT, Veeger NJ, Matthews AG, Navis G, Hillege HL, van der Meer J; Prevention of Renal and Vascular EndstageDisease (PREVEND) Study Group: Microalbuminuria and risk of venous thromboembolism. JAMA 301: 1790-1797, 2009
15. Tveit DP, Hypolite IO, Hshieh P, Cruess D, Agodoa LY, Welch PG, Abbott KC: Chronic dialysis patients have high risk for pulmonary embolism. Am J Kidney Dis 39: 1011-1017, 2002
16. Casserly LF, Reddy SM, Dember LM: Venous thromboembolism in end-stage renal disease. Am J Kidney Dis 36: 405-411, 2000
17. Guntupalli K, Soffer O, Baciewicz P: Pulmonary embolismin end stage renal disease. Intensive Care Med 16: 405-407, 1990
18. Ifudu O, Delaney VB, Barth RH, Friedman EA: Deep vein thrombosis in end-stage renal disease. ASAIO J 40: 103-105, 1994
19. Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project: Introduction to the HCUP Nationwide Inpatient Sample (NIS), 2008. Available at: http://www.hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2008.jsp. Accessed November 26, 2011
20. White RH, Garcia M, Sadeghi B, Tancredi DJ, Zrelak P, Cuny J, Sama P, Gammon H, Schmaltz S, Romano PS: Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States. Thromb Res 126: 61-67, 2010
21. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: 613-619, 1992
22. US Renal Data System: Chronic kidney disease identified in the claims data. In: Atlas of Chronic Kidney Disease. Available at: http://www.usrds.org/2009/pdf/V1_03_09.pdf. Accessed November 10, 2011
23. US Census Bureau: American FactFinder. Available at: http://factfinder.census.gov. Accessed November 10, 2011
24. Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107: 87-92, 2003
25. Thijs A, Nanayakkara PW, Ter Wee PM, Huijgens PC, van Guldener C, Stehouwer CD: Mild-to-moderate renal impairment is associated with platelet activation: A cross-sectional study. Clin Nephrol 70: 325-331, 2008
26. Hrafnkelsdóttir T, Ottosson P, Gudnason T, Samuelsson O, Jern S: Impaired endothelial release of tissue-type plasminogen activator in patients with chronic kidney disease and hypertension. Hypertension 44: 300-304, 2004
27. Pawlak K, Tankiewicz J, Mysliwiec M, Pawlak D: Tissue factor/its pathway inhibitor system and kynurenines in chronic kidney disease patients on conservative treatment. Blood Coagul Fibrinolysis 20: 590-594, 2009
28. Matsuo T, Koide M, Kario K, Suzuki S, Matsuo M: Extrinsic coagulation factors and tissue factor pathway inhibitor in end-stage chronic renal failure. Haemostasis 27: 163-167, 1997
29. Takagi M, Wada H, Mukai K, Minamikawa K, Wakita Y, Deguchi K, Junji N, Hayashi T, Suzuki K, Shiku H: Increased activated protein C: Protein C inhibitor complex and decreased protein C inhibitor levels in patients with chronic renal failure on maintenance hemodialysis. Clin Appl Thromb Hemost 5: 113-116, 1999
30. Tomura S, Nakamura Y, Deguchi F, Ando R, Chida Y, Marumo F: Coagulation and fibrinolysis in patients with chronic renal failure undergoing conservative treatment. Thromb Res 64: 81-90, 1991
31. Gawaz MP, Dobos G, Späth M, Schollmeyer P, Gurland HJ, Mujais SK: Impaired function of plateletmembrane glycoprotein IIb-IIIa in end-stage renal disease. J Am Soc Nephrol 5: 36-46, 1994
32. Pawlak D, Malyszko J, Malyszko JS, Pawlak K, Buczko W, Mysliwiec M: Peripheral serotonergic system in uremia. Thromb Res 83: 189-194, 1996
33. Di Minno G, Cerbone A, Usberti M, Cianciaruso B, Cortese A, Farace MJ, Martinez J, Murphy S: Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen. J Lab Clin Med 108: 246-252, 1986
34. Noris M, Benigni A, Boccardo P, Aiello S, Gaspari F, Todeschini M, Figliuzzi M, Remuzzi G: Enhanced nitric oxide synthesis in uremia: Implications for platelet dysfunction and dialysis hypotension. Kidney Int 44: 445-450, 1993
35. Jalal DI, Chonchol M, Targher G: Disorders of hemostasis associated with chronic kidney disease. Semin Thromb Hemost 36: 34-40, 2010
36. Bostom AG, Lathrop L: Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52: 10-20, 1997
37. Sagripanti A, Cupisti A, Baicchi U, Ferdeghini M, Morelli E, Barsotti G: Plasma parameters of the prothrombotic state in chronic uremia. Nephron 63: 273-278, 1993
38. Camici M, Evangelisti L, Balestri P, Cioni L, Rindi P, Sagripanti A, Meriggioli M, Giordani R: Coagulation activation in extracorporeal hemodialysis. Int J Artif Organs 20: 163-165, 1997
39. Churchill DN, Muirhead N, Goldstein M, Posen G, Fay W, Beecroft ML, Gorman J, Taylor DW: Probability of thrombosis of vascular access among hemodialysis patients treated with recombinant human erythropoietin. J Am Soc Nephrol 4: 1809-1813, 1994
40. Ghisdal L, Broeders N, Wissing KM, Mena JM, Lemy A, Wijns W, Pradier O, Donckier V, Racapé J, Vereerstraeten P, Abramowicz D: Thrombophilic factors in Stage V chronic kidney disease patients are largely corrected by renal transplantation. Nephrol Dial Transplant 26: 2700-2705, 2011
41. Mossey RT, Kasabian AA, Wilkes BM, Mailloux LU, Susin M, Bluestone PA: Pulmonary embolism: Low incidence in chronic renal failure. Arch Intern Med 142: 1646-1648, 1982
42. Wiesholzer M, Kitzwögerer M, Harm F, Barbieri G, Hauser AC, Pribasnig A, Bankl H, Balcke P: Prevalence of preterminal pulmonary thromboembolism among patients on maintenance hemodialysis treatment before and after introduction of recombinant erythropoietin. AmJ KidneyDis 33: 702-708, 1999
43. Daneschvar HL, Seddighzadeh A, Piazza G, Goldhaber SZ: Deep vein thrombosis in patients with chronic kidney disease. Thromb Haemost 99: 1035-1039, 2008
44. Monreal M, Falgá C, Valle R, Barba R, Bosco J, Beato JL, Maestre A; RIETE Investigators: Venous thromboembolism in patients with renal insufficiency: Findings from the RIETE Registry. Am J Med 119: 1073-1079, 2006